Literature DB >> 6657880

Psychosomatic aspects of hyperprolactinemia.

M Fava, G A Fava, R Kellner, M T Buckman, J Lisansky, E Serafini, L DeBesi, I Mastrogiacomo.   

Abstract

A review of some recent studies on the psychosomatic aspects of hyperprolactinemia is presented. Women seem to be more prone to suffer from the behavioral effects of prolactin than males. Women with hyperprolactinemic amenorrhea rated themselves significantly more hostile, more depressed and more anxious than women with amenorrhea only and other control groups. Hyperprolactinemic males did not rate themselves more hostile and depressed than matched controls. Psychological distress and hostility appear to remit upon treatment with bromocriptine. Postpartum patients matched for prolactin levels with hyperprolactinemic women showed significantly less depression and anxiety but about the same levels of hostility. Hostility, depression and loss of libido may coexist in the same hyperprolactinemic patient but they may be also present independently.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6657880     DOI: 10.1159/000287773

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN: 0033-3190            Impact factor:   17.659


  8 in total

1.  Antipsychotic-induced euprolactinemic galactorrhea in an adolescent girl: a case report.

Authors:  Woo Jin Kwak; Ankit Patel; Fasiha Haq; Fatima Siddiqui; Mohammad Younis; Shakeel Raza; Radhika Gholkar
Journal:  Prim Care Companion CNS Disord       Date:  2012-02-02

2.  Postmortem prolactin as a marker of antemortem stress.

Authors:  T J Jones; M J Hallworth
Journal:  J Clin Pathol       Date:  1999-10       Impact factor: 3.411

3.  Prolactin, amitriptyline, and recovery from depression.

Authors:  J Lisansky; G A Fava; M T Buckman; R Kellner; M Fava; M Zielezny; G T Peake
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

4.  Psychosomatic aspects of galactorrhea.

Authors:  M Langer; J Fiegl; V Riegel; R Prohaska; E Kubista; M Ringler
Journal:  Arch Gynecol Obstet       Date:  1991       Impact factor: 2.344

5.  Impact of Antipsychotics on Geriatric Patients: Efficacy, Dosing, and Compliance.

Authors:  Gerald A. Maguire
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2000-10

6.  Risk factors for suicide behaviors in the observational schizophrenia outpatient health outcomes (SOHO) study.

Authors:  Roberto Brugnoli; Diego Novick; Josep Maria Haro; Andrea Rossi; Marco Bortolomasi; Sonia Frediani; Giuseppe Borgherini
Journal:  BMC Psychiatry       Date:  2012-07-19       Impact factor: 3.630

7.  Sexual function and depressive symptoms in young women with elevated macroprolactin content: a pilot study.

Authors:  Robert Krysiak; Agnieszka Drosdzol-Cop; Violetta Skrzypulec-Plinta; Bogusław Okopien
Journal:  Endocrine       Date:  2016-02-22       Impact factor: 3.633

8.  Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin).

Authors:  Deanna L Kelly; Heidi J Wehring; Amber K Earl; Kelli M Sullivan; Faith B Dickerson; Stephanie Feldman; Robert P McMahon; Robert W Buchanan; Dale Warfel; William R Keller; Bernard A Fischer; Joo-Cheol Shim
Journal:  BMC Psychiatry       Date:  2013-08-22       Impact factor: 3.630

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.